By: A. Enguita PhD
Described for the first time in 2020, VEXAS, an adult-onset ‘haemato-inflammatory syndrome’, is still largely unexplored. At the 2024 General Annual Meeting of the Belgian Hematology Society, Dr. Jérome Hadjadj (Hôpital Saint-Antoine, Paris, France) discussed the current understanding of this disease, covering its clinical manifestations, prognosis and potential treatments based on the knowledge available to date.
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
